BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM

  May 9, 2025

   · 

  8 min read
• Press Releases

  Apotex introduces IVRA™ (Melphalan) hydrochloride injection: First ready to dilute liquid formulation of Melphalan injection approved via 505(b)(2) NDA in the United States

  May 9, 2025

   · 

  1 min read
• Press Releases

  SystImmune, Inc. to Present Updated izalontamab brengitecan (iza-bren) Data in Locally Advanced or Metastatic Breast Cancer at ESMO Breast 2025

  May 9, 2025

   · 

  4 min read
• Press Releases

  Cognition Therapeutics Presented Data at Association for Research in Vision and Ophthalmology Showing Impact on Retinal Cell Health

  May 9, 2025

   · 

  8 min read
• Press Releases

  Soligenix Announces Recent Accomplishments And First Quarter 2025 Financial Results

  May 9, 2025

   · 

  8 min read
• Press Releases

  Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025

  May 9, 2025

   · 

  2 min read
• Press Releases

  Ocugen Provides Business Update with First Quarter 2025 Financial Results

  May 9, 2025

   · 

  12 min read
• Press Releases

  BlossomHill Therapeutics Appoints Jason Keyes as Chief Financial Officer and Executive Vice President

  May 9, 2025

   · 

  3 min read
• Press Releases

  LEO Pharma announces Positive Topline Phase 2b Results for Temtokibart in Moderate-to-Severe Atopic Dermatitis

  May 9, 2025

   · 

  5 min read
• Press Releases

  Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B From the MARCH Study

  May 9, 2025

   · 

  9 min read